Related Experiment Videos
Distribution volume ratios without blood sampling from graphical analysis of PET data
J Logan1, J S Fowler, N D Volkow
1Chemistry Department, Brookhaven National Laboratory, Upton, NY 11973, USA.
Summary
This study introduces a new graphical method for calculating the distribution volume ratio (DVR) in brain imaging, eliminating the need for blood sampling. This non-invasive technique provides accurate receptor availability measurements comparable to traditional methods.
Area of Science:
- Nuclear Medicine
- Radiochemistry
- Neuroscience
Background:
- Distribution Volume Ratio (DVR) is crucial for quantifying receptor availability in imaging.
- Traditional DVR calculation requires invasive arterial input function measurements.
- Developing non-invasive methods is essential for broader clinical application.
Purpose of the Study:
- To develop and validate a graphical method for determining DVR without arterial blood sampling.
- To compare the accuracy of the novel method against a standard blood-sampling method.
- To assess the applicability of the method for different radioligands.
Main Methods:
- A novel graphical analysis was developed using data from a non-receptor region to approximate plasma integrals.
- Positron Emission Tomography (PET) studies with [11C]raclopride and [11C]d-threo-methylphenidate were conducted.
- Results from the non-invasive method were compared to a conventional method using arterial plasma data.
Main Results:
- The novel graphical method yielded results highly similar to the conventional method.
- Average percentage differences for DVR were minimal (-0.11% for [11C]raclopride, 0.46% for [11C]dMP).
- Both methods produced comparable DVR images, demonstrating good agreement.
Conclusions:
- A non-invasive graphical method for DVR calculation is effective and provides equivalent results to blood-sampling methods.
- This technique simplifies imaging studies by removing the need for arterial input function measurement.
- Initial studies are needed to determine kinetic constants and validate applicability for specific radioligands.